3-53673826-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000720.4(CACNA1D):​c.1220+10C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00389 in 1,571,500 control chromosomes in the GnomAD database, including 176 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0042 ( 24 hom., cov: 32)
Exomes 𝑓: 0.0039 ( 152 hom. )

Consequence

CACNA1D
NM_000720.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.77

Publications

1 publications found
Variant links:
Genes affected
CACNA1D (HGNC:1391): (calcium voltage-gated channel subunit alpha1 D) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, namely alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1D subunit. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
CACNA1D Gene-Disease associations (from GenCC):
  • aldosterone-producing adenoma with seizures and neurological abnormalities
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Illumina, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • sinoatrial node dysfunction and deafness
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 3-53673826-C-T is Benign according to our data. Variant chr3-53673826-C-T is described in ClinVar as Benign. ClinVar VariationId is 226468.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0778 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1DNM_000720.4 linkc.1220+10C>T intron_variant Intron 8 of 48 ENST00000288139.11 NP_000711.1 Q01668-2Q59GD8
CACNA1DNM_001128840.3 linkc.1220+700C>T intron_variant Intron 8 of 47 ENST00000350061.11 NP_001122312.1 Q01668-1Q59GD8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1DENST00000288139.11 linkc.1220+10C>T intron_variant Intron 8 of 48 1 NM_000720.4 ENSP00000288139.3 Q01668-2
CACNA1DENST00000350061.11 linkc.1220+700C>T intron_variant Intron 8 of 47 1 NM_001128840.3 ENSP00000288133.5 Q01668-1

Frequencies

GnomAD3 genomes
AF:
0.00424
AC:
645
AN:
152164
Hom.:
24
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00216
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.0847
Gnomad SAS
AF:
0.0166
Gnomad FIN
AF:
0.00433
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000235
Gnomad OTH
AF:
0.00431
GnomAD2 exomes
AF:
0.00963
AC:
2422
AN:
251482
AF XY:
0.0101
show subpopulations
Gnomad AFR exome
AF:
0.000554
Gnomad AMR exome
AF:
0.000318
Gnomad ASJ exome
AF:
0.000595
Gnomad EAS exome
AF:
0.0899
Gnomad FIN exome
AF:
0.00420
Gnomad NFE exome
AF:
0.000431
Gnomad OTH exome
AF:
0.00456
GnomAD4 exome
AF:
0.00385
AC:
5469
AN:
1419218
Hom.:
152
Cov.:
25
AF XY:
0.00426
AC XY:
3022
AN XY:
708860
show subpopulations
African (AFR)
AF:
0.000245
AC:
8
AN:
32656
American (AMR)
AF:
0.000381
AC:
17
AN:
44666
Ashkenazi Jewish (ASJ)
AF:
0.000851
AC:
22
AN:
25864
East Asian (EAS)
AF:
0.0766
AC:
3028
AN:
39554
South Asian (SAS)
AF:
0.0182
AC:
1558
AN:
85388
European-Finnish (FIN)
AF:
0.00386
AC:
206
AN:
53406
Middle Eastern (MID)
AF:
0.00123
AC:
7
AN:
5670
European-Non Finnish (NFE)
AF:
0.000218
AC:
234
AN:
1073022
Other (OTH)
AF:
0.00659
AC:
389
AN:
58992
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
302
604
906
1208
1510
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00421
AC:
641
AN:
152282
Hom.:
24
Cov.:
32
AF XY:
0.00485
AC XY:
361
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.000337
AC:
14
AN:
41560
American (AMR)
AF:
0.00216
AC:
33
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3472
East Asian (EAS)
AF:
0.0843
AC:
437
AN:
5182
South Asian (SAS)
AF:
0.0164
AC:
79
AN:
4818
European-Finnish (FIN)
AF:
0.00433
AC:
46
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000235
AC:
16
AN:
68020
Other (OTH)
AF:
0.00426
AC:
9
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
33
66
98
131
164
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000520
Hom.:
1
Bravo
AF:
0.00414
Asia WGS
AF:
0.0500
AC:
172
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Aug 03, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

1220+10C>T in intron 8 of CACNA1D: This variant is not expected to have clinical significance because it is not located within the conserved splice consensus se quence. It has been identified in 12.9% (25/194) of Han Chinese chromosomes from a broad population by the 1000 Genomes Project (http://www.ncbi.nlm.nih.gov/pro jects/SNP; dbSNP rs117630105). -

Aldosterone-producing adenoma with seizures and neurological abnormalities Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
18
DANN
Benign
0.86
PhyloP100
1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117630105; hg19: chr3-53707853; COSMIC: COSV55437865; API